Related Experiment Video

Updated: Sep 29, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.1K

The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead

Adam Nelson1,2, Jordan D Lukacs1,2, Brent Johnston1,2,3,4

  • 1Department of Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada.

Cancers
|October 23, 2021
PubMed

Insights

Natural killer T (NKT) cells boost anti-tumor immunity. Activating these specialized lymphocytes with glycolipids shows promise for cancer immunotherapy, with their presence linked to better patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Immunotherapy

Background:

  • Natural Killer T (NKT) cells are lipid-reactive T lymphocytes crucial for immunosurveillance and anti-tumor immunity.
  • Preclinical data indicate that activating NKT cells with exogenous glycolipids can generate a potent anti-cancer immune response.
  • The presence of NKT cells in tumors often correlates with a favorable prognosis in various cancer types.

Purpose of the Study:

  • To review the multifaceted role of NKT cells in the context of cancer.
  • To summarize the current landscape of NKT cell-based immunotherapy strategies and their clinical status.
  • To identify and discuss the challenges and future prospects for enhancing NKT cell therapy efficacy.

Main Methods:

  • Literature review of preclinical and clinical studies on NKT cells in cancer.
  • Analysis of NKT cell activation mechanisms and their impact on anti-tumor immunity.
  • Synthesis of data regarding NKT cell immunotherapy approaches, including challenges and future directions.

Main Results:

  • NKT cells contribute to anti-tumor immunity through direct and indirect mechanisms.
  • Exogenous glycolipid administration effectively activates NKT cells, stimulating anti-cancer immune responses.
  • NKT cell infiltration is a positive prognostic biomarker in several human malignancies.

Conclusions:

  • NKT cells represent a promising target for cancer immunotherapy.
  • Current NKT cell immunotherapy strategies require further optimization to overcome existing challenges.
  • Future research should focus on refining NKT cell activation and delivery methods to maximize therapeutic benefits in cancer patients.
Keywords:
CAR-NKT cellsadoptive transferscancercancer vaccinescheckpoint inhibitorsiNKT cellsimmunotherapynatural killer T cellstype II NKT cellsα-galactosylceramide

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.3K
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

10.1K

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
432
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
699
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
537
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K